$THMG
THUNDER MOUNTAIN GOLD INC

2021 Q4 Form 10-K Financial Statement

#000106299322008328 Filed on March 22, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $75.00K $800.0K $75.00K
YoY Change 0.0% 45.45% -76.92%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $87.88K $429.0K $95.48K
YoY Change -7.96% -23.13% -10.13%
% of Gross Profit
Research & Development -$2.800K $9.840K
YoY Change -13.0%
% of Gross Profit
Depreciation & Amortization $620.00 $2.850K $5.240K
YoY Change -88.17% -86.4% -35.07%
% of Gross Profit
Operating Expenses $85.70K $441.7K $98.61K
YoY Change -13.09% -25.18% -13.94%
Operating Profit $273.0K
YoY Change
Interest Expense -$27.77K -$849.0K -$175.1K
YoY Change -84.14% -166.98% -246.66%
% of Operating Profit -310.98%
Other Income/Expense, Net $830.00 $9.210K $1.700K
YoY Change -51.18% 234.91% -159.44%
Pretax Income -$54.26K -$566.8K -$159.2K
YoY Change -65.92% -146.4% -150.32%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$59.26K -$571.8K -$164.2K
YoY Change -63.91% -146.8% -152.73%
Net Earnings / Revenue -79.01% -71.48% -218.95%
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share -$1.005K -$9.469K -$2.730K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding 60.38M shares

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.157M $1.157M $274.2K
YoY Change 321.88% 321.88% 8.61%
Cash & Equivalents $1.157M $1.157M $274.2K
Short-Term Investments
Other Short-Term Assets $18.39K $18.39K $20.13K
YoY Change -8.64% -8.64% 6.96%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $1.175M $1.175M $294.3K
YoY Change 299.28% 299.28% 8.49%
LONG-TERM ASSETS
Property, Plant & Equipment $282.4K $282.4K $285.3K
YoY Change -1.0% -1.46% -11.64%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.521M $1.521M $3.019M
YoY Change -49.62% -49.62% 73.9%
Other Assets
YoY Change
Total Long-Term Assets $1.803M $1.803M $3.305M
YoY Change -45.45% -45.45% 60.55%
TOTAL ASSETS
Total Short-Term Assets $1.175M $1.175M $294.3K
Total Long-Term Assets $1.803M $1.803M $3.305M
Total Assets $2.978M $2.978M $3.600M
YoY Change -17.26% -17.26% 54.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.50K $11.50K
YoY Change -80.96%
Accrued Expenses $166.7K $246.9K $276.6K
YoY Change -39.73% -10.74% -9.41%
Deferred Revenue
YoY Change
Short-Term Debt $66.77K $66.77K $106.6K
YoY Change -37.35% -37.35% 0.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.403M $1.403M $1.523M
YoY Change -7.92% -7.92% -6.47%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $65.00K $65.00K $65.00K
YoY Change 0.0% 0.0% -2.05%
Total Long-Term Liabilities $65.00K $65.00K $65.00K
YoY Change 0.0% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.403M $1.403M $1.523M
Total Long-Term Liabilities $65.00K $65.00K $65.00K
Total Liabilities $1.468M $1.642M $1.762M
YoY Change -16.7% -6.84% -5.72%
SHAREHOLDERS EQUITY
Retained Earnings -$5.107M
YoY Change
Common Stock $60.86K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares 11.70K shares 11.70K shares
Shareholders Equity $1.337M $1.337M $1.837M
YoY Change
Total Liabilities & Shareholders Equity $2.978M $2.978M $3.600M
YoY Change -17.26% -17.26% 54.49%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income -$59.26K -$571.8K -$164.2K
YoY Change -63.91% -146.8% -152.73%
Depreciation, Depletion And Amortization $620.00 $2.850K $5.240K
YoY Change -88.17% -86.4% -35.07%
Cash From Operating Activities -$58.96K -$257.8K -$64.57K
YoY Change -8.69% -4.95% 550.25%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $1.150M $0.00
YoY Change 359.82% -100.0%
Cash From Investing Activities $0.00 $1.150M $0.00
YoY Change 359.82% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -5.000K -9.270K -5.000K
YoY Change 0.0% -121.56% -85.71%
NET CHANGE
Cash From Operating Activities -58.96K -257.8K -64.57K
Cash From Investing Activities 0.000 1.150M 0.000
Cash From Financing Activities -5.000K -9.270K -5.000K
Net Change In Cash -63.96K 882.5K -69.57K
YoY Change -8.06% -4250.85% -133.93%
FREE CASH FLOW
Cash From Operating Activities -$58.96K -$257.8K -$64.57K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Auditor Name
AuditorName
Assure CPA LLC
CY2021 dei Auditor Location
AuditorLocation
Spokane, Washington
CY2021 dei Auditor Firm
AuditorFirmId
444
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1332 USD
CY2021Q4 us-gaap Available For Sale Securities Equity Securities Noncurrent
AvailableForSaleSecuritiesEquitySecuritiesNoncurrent
1520684 USD
CY2020Q4 us-gaap Available For Sale Securities Equity Securities Noncurrent
AvailableForSaleSecuritiesEquitySecuritiesNoncurrent
3018634 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1332 USD
CY2021Q4 us-gaap Accrued Reclamation Costs Current
AccruedReclamationCostsCurrent
65000 USD
CY2020Q4 us-gaap Accrued Reclamation Costs Current
AccruedReclamationCostsCurrent
65000 USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
60145579 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
60145579 shares
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
11700 shares
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
60855579 shares
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.02
CY2020 us-gaap Net Income Loss
NetIncomeLoss
1221681 USD
CY2020 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
1282804 USD
CY2021 us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
500000 USD
CY2020 us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
250000 USD
CY2021 thmg Loan Forgiveness
LoanForgiveness
0 USD
CY2020 thmg Loan Forgiveness
LoanForgiveness
48000 USD
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60384839 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61690547 shares
CY2021 thmg Loan Forgiveness
LoanForgiveness
0 USD
CY2020 thmg Loan Forgiveness
LoanForgiveness
48000 USD
CY2021 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
0 USD
CY2020 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
48000 USD
CY2021 thmg Distribution To Noncontrolling Interest
DistributionToNoncontrollingInterest
5000 USD
CY2020 thmg Distribution To Noncontrolling Interest
DistributionToNoncontrollingInterest
5000 USD
CY2020 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
5000 USD
CY2021 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
5000 USD
CY2020Q4 us-gaap Accrued Reclamation Costs Current
AccruedReclamationCostsCurrent
65000 USD
CY2020 thmg Number Of Stock Options Included In Diluted Earning Per Share
NumberOfStockOptionsIncludedInDilutedEarningPerShare
5707000 shares
CY2021 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
60384839 shares
CY2020 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
60145579 shares
CY2021 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2020 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1544968 shares
CY2021 us-gaap Pro Forma Weighted Average Shares Outstanding Diluted
ProFormaWeightedAverageSharesOutstandingDiluted
60384839 shares
CY2020 us-gaap Pro Forma Weighted Average Shares Outstanding Diluted
ProFormaWeightedAverageSharesOutstandingDiluted
61690547 shares
CY2020Q2 us-gaap Notes Payable To Bank Noncurrent
NotesPayableToBankNoncurrent
48000 USD
CY2020Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.01 pure
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5035000 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.09
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5705000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.10
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3355000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.10
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
169855 USD
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
710000 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
18460 USD
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements State And Local
EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal
0.267 pure
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
0 USD
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.000 pure
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
12600 USD
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.010 pure
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2019Q1 thmg Right Of Use Lease Asset At Inception
RightOfUseLeaseAssetAtInception
29617 USD
CY2019Q1 thmg Incremental Borrowing Rate To Discount Future Rent Payments
IncrementalBorrowingRateToDiscountFutureRentPayments
0.080 pure
CY2019Q1 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
1300 USD
CY2019Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P2Y

Files In Submission

Name View Source Status
0001062993-22-008328-index-headers.html Edgar Link pending
0001062993-22-008328-index.html Edgar Link pending
0001062993-22-008328.txt Edgar Link pending
0001062993-22-008328-xbrl.zip Edgar Link pending
exhibit21-1.htm Edgar Link pending
exhibit31-1.htm Edgar Link pending
exhibit31-2.htm Edgar Link pending
exhibit32-1.htm Edgar Link pending
exhibit32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10k.htm Edgar Link pending
form10kxz001.jpg Edgar Link pending
form10kxz002.jpg Edgar Link pending
form10kxz003.jpg Edgar Link pending
form10kxz004.jpg Edgar Link pending
form10kxz005.jpg Edgar Link pending
form10kxz006.jpg Edgar Link pending
form10k_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
thmg-20211231.xsd Edgar Link pending
thmg-20211231_cal.xml Edgar Link unprocessable
thmg-20211231_def.xml Edgar Link unprocessable
thmg-20211231_lab.xml Edgar Link unprocessable
thmg-20211231_pre.xml Edgar Link unprocessable